Is Cannabis Safe During Pregnancy? Risks & Research

Prenatal cannabis exposure refers to the use of marijuana or THC-containing products by a mother during pregnancy, a practice that is becoming increasingly common yet carries significant and often underestimated risks. While the dangers of alcohol in pregnancy are widely recognized, the conversation around cannabis is filled with misinformation. As legalization spreads and usage rates climb, understanding the real-world implications for maternal and fetal health is more critical than ever.

Cannabis use during pregnancy is not considered safe. Emerging research consistently links prenatal cannabis exposure to adverse outcomes such as low birth weight, preterm birth, and potential long-term neurodevelopmental issues in children. Health experts strongly recommend avoiding all cannabis products during pregnancy and breastfeeding.

Key Takeaways:

Birth Risks: Increased odds of preterm birth, low birth weight, and NICU admission.
Developmental Impact: Potential links to anxiety, aggression, hyperactivity, and altered stress responses in children.
Breastfeeding Concern: THC can be transferred through breast milk, posing risks to infant development.
Expert Advice: Abstinence from cannabis is the safest choice for pregnant and breastfeeding women.

The Rising Trend of Cannabis Use in Pregnancy

Cannabis remains the most commonly used illicit substance during pregnancy, and its prevalence is on the rise. Recent estimates from the National Survey on Drug Use and Health (NSDUH) indicate that between 2021 and 2023, approximately 6.8% of pregnant women reported using cannabis, with higher usage rates observed during the first trimester. This marks a notable increase from 2017 figures, where self-reported use was around 4.2%.

This upward trend is concerning given the potent nature of modern cannabis products. Yasmin Hurd, Ph.D., director of the Addiction Institute at Mount Sinai Medical Center, warns, “The reality is that cannabis is more potent today than even a few years ago. Our findings indicate that using it during pregnancy can have a long-term impact on children.” Despite this, many pregnant women are bombarded with misinformation suggesting that cannabis is a low-risk option for managing symptoms like nausea, masking the potential dangers to their developing baby.

Adverse Birth Outcomes: What the Data Shows

A growing body of research, including multiple meta-analyses and population-based cohort studies, has established a consistent link between prenatal cannabis exposure and several negative birth outcomes. Even after adjusting for factors like tobacco use, the data points to significant risks:

Low Birth Weight (LBW): Infants exposed to cannabis are more likely to weigh less than 2,500 grams at birth.
Small for Gestational Age (SGA): Babies may be smaller than expected for the number of weeks of pregnancy.
Preterm Birth (PTB): There is an increased likelihood of giving birth before 37 weeks of gestation.
NICU Admissions: Exposed newborns have higher rates of admission to neonatal intensive care units.
Perinatal Mortality: Some studies have identified an association with increased perinatal death rates.

Furthermore, a large-scale study has identified associations between prenatal cannabis use and serious maternal complications, including gestational hypertension, preeclampsia, placental abruption, and altered gestational weight-gain patterns. These findings support the view that cannabis risks affect the entire maternal-placental-fetal unit.

Looking for Manufacturer for Your Vape Business?

ECIGATOR

Ecigator is one of the well-known vape brands spun off from FM Technology Co., Ltd, it’s an ISO-certified disposable vape manufacturer for OEMs, ODMs, and OBM since 2010. The founder team comes from top firms with more than 10 years of experience in the vaping industry and has devoted thousands of hours to providing users with a better and better experience.

check details >

Long-Term Neurodevelopmental and Behavioral Effects

The impact of cannabis does not end at delivery. The fetal central nervous system is particularly vulnerable to chemical exposures during critical periods of growth. Research into the long-term effects on children has revealed concerning patterns:

Behavioral Issues: Children of mothers who used cannabis during pregnancy show higher rates of anxiety, aggression, and hyperactivity compared to non-exposed peers.
Stress Response: Maternal cannabis use is associated with higher levels of the stress hormone cortisol in children. It also correlates with a reduction in the high-frequency component of heart rate variability, a marker that normally reflects the body’s ability to manage stress.
Genetic Expression: Analyses of placental tissue have shown that maternal cannabis use is linked to lower expression of key immune-activating genes. This genetic alteration predicted higher anxiety levels in the children of these mothers.
Neurodevelopmental Disorders: Some meta-analyses report increased symptoms of ADHD and Autism Spectrum Disorder (ASD) among exposed children, although findings on ASD are mixed and ADHD risks appear modestly elevated.

Cannabis and Breastfeeding: A Continued Risk

The recommendation to avoid cannabis extends through the breastfeeding period. Prospective studies have demonstrated that THC and other cannabinoids are measurable in human milk. Because these compounds are stored in fat, concentrations can remain elevated with repeated use.

Infants in their first months of life have immature metabolism and kidney-clearance rates. This physiological immaturity prevents them from effectively detoxifying and excreting chemicals, potentially leading to higher levels of toxic substances accumulating in their systems. Consequently, frequent maternal use is associated with higher infant exposure, posing unknown but likely detrimental risks to the rapidly developing infant brain.

The Context of Alcohol and Polysubstance Use

While this discussion focuses on cannabis, it is impossible to ignore the broader context of substance use. Alcohol use during pregnancy remains roughly twice as common as cannabis use, with no safe amount, timing, or type established. Crucially, cannabis use frequently co-occurs with nicotine and alcohol consumption. Combined drug exposures amplify risks, with studies reporting higher rates of maternal morbidity, neonatal morbidity, and infant death among those exposed to both cannabis and nicotine compared to either substance alone.

Conclusion: The Safest Choice is Abstinence

The emerging data on cannabis and pregnancy paints a clear picture: it is not a benign substance for expectant mothers or their babies. From immediate birth complications like low birth weight and preterm delivery to long-term behavioral and neurodevelopmental challenges, the potential consequences are significant. “Pregnant women are being bombarded with misinformation,” notes Dr. Hurd, underscoring the urgent need for non-biased education.

For women who are pregnant, planning to become pregnant, or breastfeeding, the safest course of action is to avoid cannabis entirely. As research continues to evolve, it is likely to uncover further evidence of risks rather than safety. Prioritizing a substance-free pregnancy is the best investment in the future health and well-being of both mother and child.

Author
Recent Posts

Sophia Bennett

Author at Ecigator

Sophia Bennett has dedicated her career to monitoring and analyzing the regulatory landscape and news within the vape industry. With a keen eye for the evolving policies that shape this dynamic market, Sophia brings a critical perspective to her commentary and reports.

Latest posts by Sophia Bennett (see all)